Animalcare Grp Regulatory News (ANCR)

Animalcare Group plc

Directorate changes

Animalcare Group plc (AIM: ANCR), a leading supplier of veterinary medicines, announces that Peter Warner, the Company's Chief Financial Officer and Company Secretary, will step down from the Board and that Raymond Harding has been appointed to the Board as a Non-Executive Director, both with immediate effect.

Peter Warner, who was previously Group Financial Controller before becoming Chief Financial Officer of Animalcare Group plc in October 2010, is expected to leave the Company before 31 December 2011. The process of finding a replacement for Peter has begun and the Company expects to announce further updates in due course.

Raymond Harding, aged 61, was until 2010 owner Managing Director of Cyton Bioscience Ltd., a multi-service consultancy for both animal health and pharmaceutical industries. Raymond remains a Consultant for Cyton advising and providing training on new product development and registration in Europe.

Raymond has been both Chairman of the Association of Veterinarians in Industry and President of the Federation of European Veterinarians in Industry and Research. In addition, Raymond is a member of the Institute of Directors and is a Fellow of The Organisation for Professionals in Regulatory Affairs.

Earlier in his career, Raymond has held positions at Glaxo Animal Health in the United Kingdom and Rhône Mérieux in France. He is a qualified veterinarian having completed his Bachelor of Veterinary Medicine and been admitted into the Royal College of Veterinary Surgeons.

Stephen Wildridge, CEO of Animalcare Group plc, said, "We are very pleased to announce Raymond's appointment to the Board. Raymond's credentials in the veterinary world speak for themselves and we are very pleased to have attracted someone of his calibre to our business."

"In addition, I would like to express thanks to Peter on behalf of the Board and Shareholders for his contribution to the growth and development of Animalcare over the last few years and my personal thanks for his help and support during the time we worked together."

For further information:

Additional Information

Raymond Bryan Harding (aged 61) holds no shares in the Company and other than as set out below there is no further information to be disclosed under schedule 2(g) and Rule 17 of the AIM Rules in respect of his appointment as a Director of the Company.

Raymond Harding is a director/partner or has been a director/partner of the following companies/partnerships during the previous five years: